Anticonvulsant activity of 4-urea-5,7-dichlorokynurenic acid derivatives that are antagonists at the NMDA-associated glycine binding site

Molecular and Chemical Neuropathology

Volumn 35, Issue 1-3, 1998, Pages 1-12

  Nichols, Alfred C ^a   Yielding, K Lemone ^a  

^a UNIVERSITY OF NORTH ALABAMA   (United States)

Author keywords

Epilepsy; Glycine receptor antagonists; Kynurenic acid; NMDA; Quinoline

Indexed keywords

4 UREA 5,7 DICHLOROKYNURENIC ACID; ANTICONVULSIVE AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICONVULSANT THERAPY; ARTICLE; BINDING SITE; DRUG EFFECT; DRUG SYNTHESIS; EPILEPSY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; BINDING SITES; DRUG DESIGN; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; KYNURENIC ACID; MALE; MICE; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0032937613     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815112     Document Type: Article

References (26)

1. Alvares A. P. and Pratt W. B. (1990) Pathways of drug metabolism, in Principles of Drug Action (Pratt W. B. and Taylor P., ed.), pp. 365-422, Churchill Livingstone, New York.
2. 3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites. Eur. J. Pharmacol. 206, 149-154.
3. 3H]dichlorokynurenic acid. J. Pharm. Pharmacol. 44, 812-816.
4. Devinsky O. (1995) Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 36(Suppl. 2), S46-S65.
5. Dingledine R., McBain C. J., and McNamara J. O. (1990) Excitatory amino acid receptors in epilepsy. Trends Pharmacol. Sci. 11, 334-338.
6. Ferrendelli J. A. (1995) Rational polypharmacy. Epilepsia 36(Suppl. 2), S115-S118.
7. Goehring R. R., Greenwood T. D., Nwokogu G. C., Pisipati J. S., Rogers T. G., and Wolfe J. F. (1990) Synthesis and anticonvulsant activity of 2-benzylglutarimides. J. Med. Chem. 33, 926-931.
8. Harrison B. L., Baron B. M., Cousion D. M., and McDonald I. A. (1990) 4-[(Carboxymethyl)oxy]-and 4-[(carboxymethyl)amino]-5,7-dichloroquinoline-2-carboxylic acid: new antagonists of the strychine-insensitive glycine binding site on the N-methyl-D-aspartate receptor complex. J. Med. Chem. 33, 3130-3132.
9. Johnson J. W. and Ascher P. (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325, 529-531.
10. 3H]TCP binding: effects of glycine, magnesium and N-methyl-D-aspartate agonists. Eur. J. Pharmacol. 152, 141-146.
11. 3H]TCP binding to rat cortical membranes: effects of divalent cations and glycine, in Sigma and Phencylidine-like Compounds as Molecular Probes in Biology (Domino E. F. and Kamenka J. M., ed.), pp. 259-268, NPP Books, Ann Arbor, MI.
12. Jones S. M., Snell L. D., and Johnson K. M. (1989). Characterization of the binding of radioligands to the N-methyl-D-aspartate, phencyclidine, and glycine receptors in buffy coat membranes. J. Pharmacol. Methods 21, 161-168.
13. Kemp J. A. and Leeson P. D. (1993) The glycine site of the NMDA receptor - five years on. Trends Pharmacol Sci. 14, 20-25.
14. Kemp J. A., Foster A. C., Leeson P. D., Priestley T., Tridgett R., Iversen L. L., et al. (1988) 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc. Natl. Acad. Sci. USA 85, 6547-6550.
15. Leeson P. D., Carling R. W., Moore K. W., Moseley A. M., Smith J. D., Stevenson G., et al. (1992) 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor. J. Med. Chem. 35, 1954-1968.
16. Nichols A. C. and Yielding K. L. (1993) Anticonvulsant activity of antagonists for the NMDA-associated glycine binding site. Mol. Chem. Neuropathol. 19, 269-282.
17. Nowak L., Bregestovski P., Ascher P., Herbet A., and Prochianta A. (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307, 462-465.
18. Piredda S. G., Woodhead J. H., and Swinyard E. A. (1985) Effect of stimulus intensity on the profile of anticonvulsant activity of phenytoin, ethosuximide and valproate. J. Pharmacol. Exp. Ther. 232, 741-745.
19. Rowley M., Leeson P. D., Stevenson G. I., Moseley A. M., Stansfield I., Sanderson I., et al. (1993) 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site on the N-methyl-D-aspartate receptor complex. J. Med. Chem. 36, 3386-3396.
20. Singh L., Menzies R., and Tricklebank M. D. (1990) The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-D-aspartate receptor. Eur. J. Pharmacol. 186, 129-132.
21. 3H](+)-MK 801 binding to rat brain sections by CPP and 7-chlorokynurenic acid: an autoradiographic analysis. Br. J. Pharmacol. 108, 577-582.
22. Watkins J. C., Krogsgaard-Larsen P., and Honore T. (1990) Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol. Sci. 11, 25-33.
23. 3H]muscimol, a potent gamma-aminobutyric acid agonist, to rat brain synaptosomal membranes using a filtration assay. J. Neurochem. 32, 713-718.
24. 3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol. Pharmacol. 22, 627-635.
25. Wong E. H. F., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N., and Iversen L. L. (1986) The anticonvulsant MK-801 is a potent N-methyl-D-asparate antagonist. Proc. Natl. Acad. Sci. USA 83, 7104-7108.
26. Wright R. G. M. (1984) A simple one-pot conversion of alkyl 4-oxo-1,4-dihydroquinoline-2-carboxylates to 4-aminoquinoline 2-carboxylates using reactive isocyanates. Synthesis 1058-1061.